August 20, 2017 11:41 PM ET

Pharmaceuticals

Company Overview of Umecrine Mood AB

Company Overview

Umecrine Mood AB develops products to treat negative mental and physical symptoms associated with premenstrual dysphoric disorder (PMDD) and serve premenstrual syndrome (PMS) caused by endogenous CNS-active steroids derived from the corpus luteum of the ovary. Its portfolio includes lead compounds and the selected drug candidate that inhibits the provocateur to act on the emotional center of the brain. The company was founded in 2006 and is based in Solna, Sweden. Umecrine Mood AB operates as a subsidiary of Umecrine AB.

Karolinska Institutet Science Park

Fogdevreten 2

Solna,  171 65

Sweden

Founded in 2006

Phone:

46 8 52 48 44 82

Fax:

46 8 52 48 44 81

Key Executives for Umecrine Mood AB

Chief Executive officer
Chief Scientific Officer, Director, Co-Founder of Umecrine AB and CEO Of Umecrine AB
Age: 69
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Abunon AB Europe
Aditech Pharma AB Europe
Antarctic Pharma Europe
Apotek Produktion & Laboratorier AB Europe
Appetite Control Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
November 1, 2016
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Umecrine Mood AB, please visit www.asarinapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.